Submission of Scrutinizer''s report on 36th AGM resolutions.

Date: August 10, 2026 To To The Secretary The Secretary National Stock Exchange of India Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East) Dalal Street Mumbai – 400 051 Mumbai – 400 001 Trading Symbol: DIVISLAB Scrip Code: 532488 Dear Sir/ Madam, Sub: Proceedings of the 36th Annual General Meeting, Voting Results and Consolidated Scrutinizer’s Report Ref: Regulation 30 and 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 This is to inform that the 36th Annual General Meeting (AGM) of the Company was held on August 10, 2026, at 10.00 a.m. through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) and the business mentioned in the Notice of 36th AGM dated May 23, 2026 was duly transacted. In this regard, we hereby submit the following: 1. Summary of proceedings of the 36th AGM along with copy of the Chairman’s speech and Managing Director’s speech delivered at the AGM as Annexure – I; 2. Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure – II; 3. The Consolidated Scrutinizer’s Report on remote e-voting and voting at AGM (by electronic means) as Annexure – III. Please note that all the resolutions set out in the Notice of 36th AGM were passed with requisite majority. This is for your information and records. Yours faithfully, For Divi’s Laboratories Limited M.Satish Choudhury Company Secretary & Compliance Officer ANNEXURE - I Summary of proceedings of the 36th Annual General Meeting of Divi’s Laboratories Limited held on Monday, August 10, 2026, at 10.00 a.m. (IST) through Video Conferencing /Other Audio-Visual Means Directors present through Video Conferencing (VC) / Other Audio-Visual Means (OAVM): S. Name Designation Location 1. Dr. Ramesh B.V. Chairman & Independent Director, Chennai Nimmagadda Chairman of Stakeholders Relationship Committee 2. Dr. Murali K. Divi Managing Director Hyderabad 3. Mr. N.V. Ramana Executive Director Hyderabad 4. Dr. Kiran S. Divi Whole-time Director & Chief Executive Hyderabad Officer, Chairman of Risk Management and Sustainability Committee 5. Ms. Nilima Prasad Divi Whole-time Director (Commercial) Hyderabad 6. Dr. S. Devendra Rao Whole-time Director (Manufacturing) Visakhapatnam 7. Prof. S. Ganapaty Independent Director and Chairman of Visakhapatnam Nomination and Remuneration Committee 8. Prof. Sunaina Singh Independent Director Hyderabad 9. Mr. K.V. Chowdary Independent Director and Chairman of Hyderabad Audit Committee 10. Dr. Rajendra Kumar Independent Director Hyderabad Premchand In attendance of the following persons present through VC / OAVM participated in the meeting: S. Name Designation Location 1. Mr. Venkatesa Perumallu Chief Financial Officer Hyderabad Pasumarthy 2. Mr. M. Satish Choudhury Company Secretary & Hyderabad Compliance Officer 3. Mr. N.K. Varadarajan Partner, Price Waterhouse Hyderabad Chartered Accountants LLP, Statutory Auditors 4. Mr. V. Bhaskara Rao Partner, V. Bhaskara Rao & Co., Hyderabad Company Secretaries, Secretarial Auditor & Scrutiniser 5. Mr. L. Kishore Babu Principal Advisor (Finance) Hyderabad Members Present: The 36th Annual General Meeting was attended by 150 members (representing 12,42,61,211 shares) through VC or OAVM. Proceedings: Dr. Ramesh B.V. Nimmagadda, Chairman of the Company, chaired the meeting and conducted the proceedings of the meeting. The requisite quorum being present, the Chairman called the meeting to order. Mr. M. Satish Choudhury, Company Secretary informed the members about general instructions regarding participation and voting at this meeting. He informed that the Annual General Meeting (AGM) was held through VC or OAVM in accordance with the Companies Act, 2013 and circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. Accordingly, the Company has provided the facility for the members for joining the meeting through VC or OAVM. It was informed that the Company has also provided webcast facility to view the live proceedings of the AGM. It was informed that the Notice of the 36th AGM and the Annual Report for the financial year ended March 31, 2026, have been sent electronically to members whose email addresses are registered with the Company or with the depositories. In addition, physical copies of the Annual Report have been sent to the members who have requested for the same. The Company has sent letters to shareholders whose email addresses are not registered with the Company or depository participants, providing the web link and QR code from where the annual report can be accessed on the Company's website. The Register of Directors and Key Managerial Personnel, the Register of Contracts or Arrangements in which Directors are interested, were made available electronically for inspection by the members during the AGM. Members were informed that the Company had provided the facility to cast the votes electronically, on all resolutions set forth in the Notice of AGM; and Members who have not cast their votes electronically and were participating in the meeting can cast their votes during the meeting through the e-voting system (Insta Poll) provided by Kfin Technologies Limited (Kfintech). The Chairman outlined the pharma industry outlook, and the Managing Director briefed the meeting on the Company’s operations during the year 2025-26, during the first quarter of the FY 2026-27 and outlook; beside updating about dividend and CSR initiatives by the Company. A copy of the Chairman’s speech and Managing Director’s speech are enclosed herewith. The Company Secretary provided summary of the Statutory Auditor’s Report and Secretarial Auditor’s Report for the year ended March 31, 2026 and informed that there were no qualifications, observations or adverse comments on financial statements and matters which have any material bearing on the functioning of the Company. The Annual Report for the year ended March 31, 2026, along with Notice of this meeting, Board’s Report, Auditor’s Reports, and the Audited Financial Statements of the Company as circulated to the members, were taken as read. The remote e-voting period commenced at 9 a.m. (IST) on Thursday, August 06, 2026, and the facility was available to the shareholders till 5 p.m. (IST) on Sunday, August 09, 2026. It was informed that there would be no voting by show of hands at the meeting. It was also informed that the Board of Directors has appointed Mr. V. Bhaskara Rao, Practicing Company Secretary (C.P No. 4182) or failing him Mr. K. Nagarjuna, Practicing Company Secretary (C.P. No. 27893), Partners of M/s. V. Bhaskara Rao & Co., Company Secretaries, Hyderabad, as the Scrutinizer for scrutiny of the votes cast through the remote e-voting platform and e-voting during the AGM. The following items of business as set out in the Notice convening the 36th Annual General Meeting were commended for Members’ consideration and approval: Sl. Resolutions Description Type of No. resolution Ordinary Business 1. To consider and adopt the audited financial statements of the Company, Ordinary both standalone and consolidated, for the financial year ended March 31, 2026, and the reports of the Board of Directors’ and Auditors’ thereon. 2. To declare dividend of ₹30/- per equity share of face value ₹2/- each (i.e. Ordinary @ 1,500%) for the financial year ended March 31, 2026. 3. To appoint a director in place of Mr. N.V. Ramana (DIN: 00005031), Ordinary who retires by rotation at this Annual General Meeting and being eligible, offers himself for re-appointment. 4. To appoint a director in place of Dr. Kiran S. Divi (DIN: 00006503), Ordinary who retires by rotation at this Annual General Meeting and being eligible, offers himself for re-appointment. The Chairman formally announced e-voting during the Meeting for all those shareholders who have not cast their votes earlier, through Insta Poll provided by Kf [Showing first 8,000 characters — download PDF for full document]